The first trial was a 13-week randomized, double-blind, placebo-controlled, parallel-group study which showed a highly significant difference in the mean serum phosphate levels between lanthanum and placebo groups ( Joy and Finn 2003 ).
← all excerpts
Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate.
1
—
—